News Tagged ‘FDA

Chantix ads back on television

Next week, Pfizer will once again be running Chantix ads on television. Pfizer stopped running Chantix ads last year amid increasing concern over the drug’s . The familiar tortoise and the hare ads will resume on Sunday, September 14, with lengthened warnings about potential . The extended warnings will occupy 41 seconds of the ad, which will run for 90 seconds – 30 seconds longer than the old ads.

Read the rest of this entry »

FMCSA stops short of Chantix ban

Following the release of the U.S. Food & Drug Administration () public health advisory on Chantix in May, the Federal Motor Carrier Safety Administration all but outright banned the use of Chantix for commercial drivers.

Read the rest of this entry »

Doctors support drug safety litigation

Attorneys who take on the pharmaceutical industry as a voice for consumers injured by medications found an unlikely ally this week, in doctors. Noting that the U.S. Food & Drug Administration is often “overwhelmed” by drug safety problems ranging from serious to unsafe manufacturing facilities, editors of the New England Journal of Medicine said patients benefit from information uncovered by attorneys during liability investigations, according to an Associated Press report released Friday.

Read the rest of this entry »

Is Chantix better than nicotine replacement?

Smoking cessation today isn’t as simple as it used to be. Years ago, smokers had a couple of choices: cold turkey or hypnotherapy. Then, as awareness about the dangers of smoking grew, thanks to efforts by the government and independent health groups, so too did the number of smoking cessation aids. First came prescription-only nicotine gum, which was quickly succeeded by a procession-soon-to-be-explosion of over-the-counter therapeutic nicotine — gum, patches, lozenges. In 1997, the approved bupropion (a.k.a. Zyban/Wellbutrin) for use in smoking cessation. Meanwhile, all sorts of gadgets and gimmicks flooded the market. And then came Chantix.

Read the rest of this entry »

More veterans enrolled in Chantix study than originally revealed

George J. Lisicki, a Vietnam combat veteran and national commander for the Veterans of Foreign Wars (VFW), had harsh words for the Veterans Administration () today.

“Those in the who failed to properly notify America’s veterans that their medication could produce fatal must resign their positions,” Lisicki said. “If not, then the secretary must take decisive action to terminate their employment.”

Read the rest of this entry »

VA warns veterans about the dangers of Chantix

Responding to widespread pressure from many congressmen, veteran’s organizations, and the general public, the Veterans Administration announced today that it would directly notify all of its veterans currently using Pfizer’s new smoking cessation drug Chantix. The number of veterans on Chantix is approximately 32,000.

Read the rest of this entry »

Veterans groups react to VA Chantix tests

This week has seen a snowballing reaction to the joint ABC/Washington Times news report about the Veterans Administration testing Chantix on soldiers with Post Traumatic Stress Disorder.

That snowball appears to be gaining speed and momentum. At least five congressman have queried the over the Chantix tests, and now a number of veteran’s groups are adding their voice to the chorus of anger.

Read the rest of this entry »

VA testing Chantix on veterans with Post Traumatic Stress

Today, ABC News and The Washington Times uncovered a story that, if proven true, exposes some enormously unethical conduct in our nation’s leadership.

According to the news organizations, the Veterans Administration chose to administer Chantix to 140 Iraq and Afghanistan veterans who have been diagnosed with Post Traumatic Stress Disorder (PTSD), ignoring Food and Drug Administration warnings that the drug has been linked to vivid dreams, psychiatric illnesses, and , to name just a handful of the drug’s potential adverse effects.

Read the rest of this entry »

More than 3,000 side effect reports

According to an article published by Bloomberg news service, a recent review of voluntary adverse event reports associated with Pfizer’s stop-smoking drug Chantix reveals more than 3,000 reports of serious in the U.S. alone. Among problems cited by the nonprofit Institute for Safe Medication Practices, which conducted the study, are , heart trouble and aggression.

Read the rest of this entry »

Charge dropped due to Chantix use

A man who disrupted a Thanksgiving Day flight and forced an emergency landing has been let off the hook for federal charges after a judge determined the man was emotionally disturbed as a result of taking the stop-smoking drug Chantix, according to an Associated Press report. The man, Andrew James Smith, 25, of California, was prescribed the drug a few weeks before the flight.

Read the rest of this entry »